Search details
1.
Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol - starting point for PET tracer development.
Biol Chem
; 404(4): 279-289, 2023 03 28.
Article
in English
| MEDLINE | ID: mdl-36215695
2.
In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs.
Biol Chem
; 404(4): 255-265, 2023 03 28.
Article
in English
| MEDLINE | ID: mdl-36427206
3.
Synthesis and biological evaluation of conformationally restricted GluN2B ligands derived from eliprodil.
Eur J Med Chem
; 237: 114359, 2022 Jul 05.
Article
in English
| MEDLINE | ID: mdl-35468513
4.
Synthesis of tropane-based σ1 receptor antagonists with antiallodynic activity.
Eur J Med Chem
; 230: 114113, 2022 Feb 15.
Article
in English
| MEDLINE | ID: mdl-35065412
5.
Ifenprodil Stereoisomers: Synthesis, Absolute Configuration, and Correlation with Biological Activity.
J Med Chem
; 64(2): 1170-1179, 2021 01 28.
Article
in English
| MEDLINE | ID: mdl-33426889
6.
Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds.
Eur J Med Chem
; 190: 112138, 2020 Mar 15.
Article
in English
| MEDLINE | ID: mdl-32070917
Results
1 -
6
de 6
1
Next >
>>